TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,000 | -53.9% | 42,201 | +36.7% | 0.00% | – |
| Q2 2023 | $766,000 | -20.0% | 30,862 | -51.5% | 0.00% | – |
| Q1 2023 | $957,000 | +20.5% | 63,654 | -5.2% | 0.00% | – |
| Q4 2022 | $794,000 | +409.0% | 67,130 | +154.6% | 0.00% | – |
| Q3 2022 | $156,000 | -29.4% | 26,372 | -49.5% | 0.00% | – |
| Q2 2022 | $221,000 | -77.1% | 52,220 | -48.5% | 0.00% | – |
| Q1 2022 | $964,000 | -31.1% | 101,420 | +37.7% | 0.00% | – |
| Q4 2021 | $1,399,000 | -15.6% | 73,654 | +47.8% | 0.00% | – |
| Q3 2021 | $1,657,000 | -36.6% | 49,831 | -26.0% | 0.00% | -100.0% |
| Q2 2021 | $2,612,000 | -41.9% | 67,328 | -27.8% | 0.00% | 0.0% |
| Q1 2021 | $4,493,000 | +394.3% | 93,192 | +433.7% | 0.00% | – |
| Q4 2020 | $909,000 | +309.5% | 17,463 | +111.2% | 0.00% | – |
| Q3 2020 | $222,000 | +57.4% | 8,268 | +14.9% | 0.00% | – |
| Q2 2020 | $141,000 | +182.0% | 7,197 | +43.1% | 0.00% | – |
| Q1 2020 | $50,000 | -56.1% | 5,028 | -50.8% | 0.00% | – |
| Q4 2019 | $114,000 | +72.7% | 10,222 | -12.9% | 0.00% | – |
| Q3 2019 | $66,000 | -39.4% | 11,735 | -7.5% | 0.00% | – |
| Q2 2019 | $109,000 | +16.0% | 12,686 | +8.8% | 0.00% | – |
| Q1 2019 | $94,000 | +95.8% | 11,655 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -7.7% | 11,655 | +26.9% | 0.00% | – |
| Q3 2018 | $52,000 | -72.2% | 9,185 | -35.3% | 0.00% | – |
| Q2 2018 | $187,000 | +76.4% | 14,198 | +91.0% | 0.00% | – |
| Q1 2018 | $106,000 | -7.8% | 7,434 | -47.0% | 0.00% | – |
| Q4 2017 | $115,000 | +82.5% | 14,027 | +162.6% | 0.00% | – |
| Q3 2017 | $63,000 | +2000.0% | 5,341 | +1800.7% | 0.00% | – |
| Q2 2017 | $3,000 | -88.5% | 281 | -87.9% | 0.00% | – |
| Q1 2017 | $26,000 | +333.3% | 2,325 | +62.7% | 0.00% | – |
| Q4 2016 | $6,000 | +500.0% | 1,429 | +1561.6% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 86 | -52.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 179 | +795.0% | 0.00% | – |
| Q1 2016 | $0 | – | 20 | +17.6% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 17 | -98.6% | 0.00% | – |
| Q3 2015 | $12,000 | +300.0% | 1,241 | +520.5% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | +50.0% | 200 | -37.5% | 0.00% | – |
| Q3 2013 | $2,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |